Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 3
An Open-label, Non-randomized Extension Study to Evaluate the Long-term Efficacy, Safety and Tolerability of Iptacopan (LNP023) in C3 Glomerulopathy or Idiopathic Immune-complex-membranoproliferative Glomerulonephritis
This is an open-label extension study to evaluate the long-term efficacy, safety and tolerability of iptacopan in subjects with C3 glomerulopathy or idiopathic…
C3 GlomerulopathyImmune-complex-membranoproliferative Glomerulonephritis
Novartis PharmaceuticalsNCT03955445
A Mobile App-Based, Prospective, Observational Study to Evaluate Disease Burden and Treatment Patterns in C3 Glomerulopathy (C3G) in the US
The study aims to longitudinally capture the full spectrum of symptoms, treatment utilization, and overall Health-related Quality of Life (HRQoL) experienced b…
C3 Glomerulopathy
Novartis PharmaceuticalsNCT07029542